ImmunoCellular Therapeutics, Ltd. (AMEX: IMUC) shares are getting slammed Thursday following the announced pricing of a common stock and warrants ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE